Synthesis and Modeling Study of
(2<i>S</i>,5<i>R</i>,6<i>R</i>)- and (2<i>S</i>,5<i>R</i>,6<i>S</i>)-6-Hydroxy-
8-(1-decynyl)-benzolactam-V8 as Protein
Kinase C Modulators
posted on 2002-06-04, 00:00authored byZhi-Liang Wei, Sukumar Sakamuri, Pavel A. Petukhov, Clifford George, Nancy E. Lewin, Peter M. Blumberg, Alan P. Kozikowski
Both (2<i>S</i>,5<i>R</i>,6<i>R</i>)- and (2<i>S</i>,5<i>R</i>,6<i>S</i>)-6-hydroxy-8-(1-decynyl)benzolactam-V8 were designed and synthesized as PKC modulators. Biological assays
reveal the (6<i>R</i>)-ligand to be 20-fold more potent than its (6<i>S</i>)-counterpart in binding to PKCα.